Johnson & Johnson Hunts For Acquisitions In Cardiovascular, Elsewhere

The world's largest medical device operation is eyeing acquisitions to bolster its "subscale" cardiovascular business, particularly its electrophysiology business, Johnson & Johnson (NYSE:JNJ) chairman & CEO Alex Gorsky told analysts yesterday.

In a conference call discussing J&J's 2nd-quarter results, Gorsky said he's interesting in shoring up the EP business, which is growing at a 14% clip.

Help employers find you! Check out all the jobs and post your resume.